Date | Time | Source | Headline | Symbol | Company |
03/03/2009 | 4:00PM | Business Wire | Allos Therapeutics Reports 2008 Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/27/2009 | 4:52PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/26/2009 | 4:00PM | Business Wire | Allos Therapeutics to Report 2008 Results on March 3, 2009 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/25/2009 | 7:49PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/25/2009 | 7:48PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/25/2009 | 7:48PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/25/2009 | 7:46PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/25/2009 | 7:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/25/2009 | 7:44PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/17/2009 | 4:24PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/13/2009 | 4:49PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/13/2009 | 4:41PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/13/2009 | 12:54PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/10/2009 | 6:03AM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/06/2009 | 6:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/06/2009 | 6:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/06/2009 | 6:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/06/2009 | 5:50PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/06/2009 | 5:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/06/2009 | 5:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/06/2009 | 11:30AM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
02/03/2009 | 5:06PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
01/23/2009 | 10:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
01/23/2009 | 9:52PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
01/05/2009 | 11:59AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/09/2008 | 4:00PM | Business Wire | Allos Therapeutics to Present at the RBC Capital Markets 2008 Healthcare Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/08/2008 | 1:15PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/07/2008 | 11:03AM | Business Wire | Allos Therapeutics Announces Top Line Results from Pivotal Phase 2 PROPEL Trial of Pralatrexate in Patients with Relapsed or ... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/06/2008 | 12:30PM | Business Wire | Two Pralatrexate Studies Presented at the 50th Annual Meeting of the American Society of Hematology | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
12/03/2008 | 8:00AM | Business Wire | Allos Therapeutics to Host Analyst and Investor Briefing on Monday, December 8, 2008 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |